The central GLP-1: Implications for food and drug reward

Frontiers in Neuroscience

Volumn , Issue 7 OCT, 2013, Pages

  Skibicka, Karolina P ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Dopamine; Ethanol reward; Exendin 9 39; Food reward; GLP 1; Gut peptides; Liraglutide; Ventral tegmental area

Indexed keywords

ALCOHOL; AMPHETAMINE; APOMORPHINE; COCAINE; DOPAMINE; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLUCOSE; KAOLIN; LIRAGLUTIDE; NICOTINE; SUCROSE;

ALCOHOL CONSUMPTION; ANOREXIA; BARIATRIC SURGERY; BODY WEIGHT; BRAIN STEM; CENTRAL NERVOUS SYSTEM; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG EFFECT; EFFERENT NERVE; ENERGY BALANCE; FEEDING BEHAVIOR; FOOD AVERSION; FOOD INTAKE; GASTROINTESTINAL TRACT; GUSTATORY SYSTEM; HUMAN; HUNGER; HYPOTHALAMUS; LIMBIC SYSTEM; MOTIVATION; MOTOR ACTIVITY; MOTOR DYSFUNCTION; NEUROANATOMY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OBESITY; PROTEIN EXPRESSION; REINFORCEMENT; REVIEW; REWARD; RHOMBENCEPHALON; ROUX Y ANASTOMOSIS; SENSORY NERVE; SIGNAL TRANSDUCTION; SOLITARY TRACT NUCLEUS; SUBSTANTIA NIGRA; TASTE AVERSION; VENTRAL TEGMENTUM; WEIGHT REDUCTION;

EID: 84888777837     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2013.00181     Document Type: Review

References (112)

1. Abegg, K., Schiesser, M., Lutz, T. A., and Bueter, M. (2013). Acute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after Roux-en-Y gastric bypass. Physiol. Behav. doi: 10.1016/j.physbeh.2013.03.027. [Epub ahead of print].
2. Abizaid, A. (2009). Ghrelin and dopamine: new insights on the peripheral regulation of appetite. J. Neuroendocrinol. 21, 787-793. doi: 10.1111/j.1365-2826.2009.01896.x
3. Abizaid, A., Liu, Z. W., Andrews, Z. B., Shanabrough, M., Borok, E., Elsworth, J. D., et al. (2006). Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J. Clin. Invest. 116, 3229-3239. doi: 10.1172/JCI29867
4. Abuirmeileh, A., Harkavyi, A., Rampersaud, N., Lever, R., Tadross, J. A., Bloom, S. R., et al. (2012). Exendin-4 treatment enhances L-DOPA evoked release of striatal dopamine and decreases dyskinetic movements in the 6-hydoxydopamine lesioned rat. J. Pharm. Pharmacol. 64, 637-643. doi: 10.1111/j.2042-7158.2011.01394.x
5. Agerso, H., Jensen, L. B., Elbrond, B., Rolan, P., and Zdravkovic, M. (2002). The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men. Diabetologia 45, 195-202. doi: 10.1007/s00125-001-0719-z
6. Alhadeff, A. L., Rupprecht, L. E., and Hayes, M. R. (2012). GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake. Endocrinology 153, 647-658. doi: 10.1210/en.2011-1443
7. Astrup, A., Carraro, R., Finer, N., Harper, A., Kunesova, M., Lean, M. E., et al. (2012). Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. Int. J. Obes. (Lond.) 36, 843-854. doi: 10.1038/ijo.2011.158
8. Astrup, A., Rossner, S., Van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., et al. (2009). Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet 374, 1606-1616. doi: 10.1016/S0140-6736(09)61375-1
9. Berridge, K. C. (1996). Food reward: brain substrates of wanting and liking. Neurosci. Biobehav. Rev. 20, 1-25. doi: 10.1016/0149-7634(95)00033-B
10. Berthoud, H. R., Lenard, N. R., and Shin, A. C. (2011). Food reward, hyperphagia, and obesity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300, R1266-R1277. doi: 10.1152/ajpregu.00028.2011
11. Buchwald, H. (2010). Metabolic surgery: a brief history and perspective. Surg. Obes. Relat. Dis. 6, 221-222. doi: 10.1016/j.soard.2009.09.001
12. Buchwald, H., and Oien, D. M. (2009). Metabolic/bariatric surgery Worldwide 2008. Obes. Surg. 19, 1605-1611. doi: 10.1007/s11695-009-0014-5
13. Calara, F., Taylor, K., Han, J., Zabala, E., Carr, E. M., Wintle, M., et al. (2005). A randomized, open-label, crossover study examining the effect of injection site on bioavailability of exenatide (synthetic exendin-4). Clin. Ther. 27, 210-215. doi: 10.1016/j.clinthera.2005.02.008
14. Carlsson, L. M., Peltonen, M., Ahlin, S., Anveden, A., Bouchard, C., Carlsson, B., et al. (2012). Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N. Engl. J. Med. 367, 695-704. doi: 10.1056/NEJMoa1112082
15. Cone, R. D. (2005). Anatomy and regulation of the central melanocortin system. Nat. Neurosci. 8, 571-578. doi: 10.1038/nn1455
16. Crespi, F. (1998). The role of cholecystokinin (CCK), CCK-A or CCK-B receptor antagonists in the spontaneous preference for drugs of abuse (alcohol or cocaine) in naive rats. Methods Find. Exp. Clin. Pharmacol. 20, 679-697. doi: 10.1358/mf.1998.20.8.487502
17. Cummings, D. E. (2009). Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery. Int. J. Obes. (Lond.) 33(Suppl. 1), S33-S40. doi: 10.1038/ijo.2009.15
18. Davis, J. F., Choi, D. L., Shurdak, J. D., Krause, E. G., Fitzgerald, M. F., Lipton, J. W., et al. (2011). Central melanocortins modulate mesocorticolimbic activity and food seeking behavior in the rat. Physiol. Behav. 102, 491-495. doi: 10.1016/j.physbeh.2010.12.017
19. Davis, J. F., Hakala-Finch, A., and Benoit, S. C. (2012a). "GLP-1 signaling decreases operant responding for ethanol in ethanol preferring rats," in Society for Neuroscience, (New Orleans, LA: Society for Neuroscience 2012 Book 5), 8.
20. Davis, J. F., Schurdak, J. D., Magrisso, I. J., Mul, J. D., Grayson, B. E., Pfluger, P. T., et al. (2012b). Gastric bypass surgery attenuates ethanol consumption in ethanol-preferring rats. Biol. Psychiatry 72, 354-360. doi: 10.1016/j.biopsych.2012.01.035
21. De Jonghe, B. C., Lawler, M. P., Horn, C. C., and Tordoff, M. G. (2009). Pica as an adaptive response: kaolin consumption helps rats recover from chemotherapy-induced illness. Physiol. Behav. 97, 87-90. doi: 10.1016/j.physbeh.2009.02.009
22. Diakogiannaki, E., Gribble, F. M., and Reimann, F. (2012). Nutrient detection by incretin hormone secreting cells. Physiol. Behav. 106, 387-393. doi: 10.1016/j.physbeh.2011.12.001
23. Di Chiara, G. (2002). Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behav. Brain Res. 137, 75-114. doi: 10.1016/S0166-4328(02)00286-3
24. Dickson, S. L., Shirazi, R. H., Hansson, C., Bergquist, F., Nissbrandt, H., and Skibicka, K. P. (2012). The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors. J. Neurosci. 32, 4812-4820. doi: 10.1523/JNEUROSCI.6326-11.2012
25. DiLeone, R. J., Taylor, J. R., and Picciotto, M. R. (2012). The drive to eat: comparisons and distinctions between mechanisms of food reward and drug addiction. Nat. Neurosci. 15, 1330-1335. doi: 10.1038/nn.3202
26. Dixit, T. S., Sharma, A. N., Lucot, J. B., and Elased, K. M. (2013). Antipsychotic-like effect of GLP-1 agonist liraglutide but not DPP-IV inhibitor sitagliptin in mouse model for psychosis. Physiol. Behav. 114-115, 38-41. doi: 10.1016/j.physbeh.2013.03.008
27. Dossat, A. M., Diaz, R., Gallo, L., Panagos, A., Kay, K., and Williams, D. L. (2013). Nucleus accumbens GLP-1 receptors influence meal size and palatability. Am. J. Physiol. Endocrinol. Metab. 304, E1314-E1320. doi: 10.1152/ajpendo.00137.2013
28. Dossat, A. M., Lilly, N., Kay, K., and Williams, D. L. (2011). Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake. J. Neurosci. 31, 14453-14457. doi: 10.1523/JNEUROSCI.3262-11.2011
29. Drucker, D. J., Dritselis, A., and Kirkpatrick, P. (2010). Liraglutide. Nat. Rev. Drug Discov. 9, 267-268. doi: 10.1038/nrd3148
30. Egecioglu, E., Steensland, P., Fredriksson, I., Feltmann, K., Engel, J. A., and Jerlhag, E. (2013). The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents. Psychoneuroendocrinology 38, 1259-1270. doi: 10.1016/j.psyneuen.2012.11.009
31. Erreger, K., Davis, A. R., Poe, A. M., Greig, N. H., Stanwood, G. D., and Galli, A. (2012). Exendin-4 decreases amphetamine-induced locomotor activity. Physiol. Behav. 106, 574-578. doi: 10.1016/j.physbeh.2012.03.014
32. Fulton, S., Pissios, P., Manchon, R. P., Stiles, L., Frank, L., Pothos, E. N., et al. (2006). Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 51, 811-822. doi: 10.1016/j.neuron.2006.09.006
33. Graham, D. L., Erreger, K., Galli, A., and Stanwood, G. D. (2012). GLP-1 analog attenuates cocaine reward. Mol. Psychiatry 106, 574-578. doi: 10.1038/mp.2012.141
34. Greig, N. H., Holloway, H. W., De Ore, K. A., Jani, D., Wang, Y., Zhou, J., et al. (1999). Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations. Diabetologia 42, 45-50. doi: 10.1007/s001250051111
35. Grill, H. J., and Hayes, M. R. (2009). The nucleus tractus solitarius: a portal for visceral afferent signal processing, energy status assessment and integration of their combined effects on food intake. Int. J. Obes. (Lond.) 33(Suppl. 1), S11-S15. doi: 10.1038/ijo.2009.10
36. Grill, H. J., and Hayes, M. R. (2012). Hindbrain neurons as an essential hub in the neuroanatomically distributed control of energy balance. Cell Metab. 16, 296-309. doi: 10.1016/j.cmet.2012.06.015
37. Grill, H. J., and Kaplan, J. M. (2002). The neuroanatomical axis for control of energy balance. Front. Neuroendocrinol. 23, 2-40. doi: 10.1006/frne.2001.0224
38. Hajnal, A., Zharikov, A., Polston, J. E., Fields, M. R., Tomasko, J., Rogers, A. M., et al. (2012). Alcohol reward is increased after Roux-en-Y gastric bypass in dietary obese rats with differential effects following ghrelin antagonism. PLoS ONE 7:e49121. doi: 10.1371/journal.pone.0049121
39. Han, V. K., Hynes, M. A., Jin, C., Towle, A. C., Lauder, J. M., and Lund, P. K. (1986). Cellular localization of proglucagon/glucagon-like peptide I messenger RNAs in rat brain. J. Neurosci. Res. 16, 97-107. doi: 10.1002/jnr.490160110
40. Harkavyi, A., Abuirmeileh, A., Lever, R., Kingsbury, A. E., Biggs, C. S., and Whitton, P. S. (2008). Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease. J. Neuroinflammation 5, 19. doi: 10.1186/1742-2094-5-19
41. Hayes, M. R., Bradley, L., and Grill, H. J. (2009). Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling. Endocrinology 150, 2654-2659. doi: 10.1210/en.2008-1479
42. Hayes, M. R., De Jonghe, B. C., and Kanoski, S. E. (2010). Role of the glucagon-like-peptide-1 receptor in the control of energy balance. Physiol. Behav. 100, 503-510. doi: 10.1016/j.physbeh.2010.02.029
43. Hayes, M. R., Skibicka, K. P., and Grill, H. J. (2008). Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation. Endocrinology 149, 4059-4068. doi: 10.1210/en.2007-1743
44. Henningfield, J. E., and Meisch, R. A. (1975). Ethanol-reinforced responding and intake as a function of volume per reinforcement. Pharmacol. Biochem. Behav. 3, 437-441. doi: 10.1016/0091-3057(75)90053-2
45. Hodos, W. (1961). Progressive ratio as a measure of reward strength. Science 134, 943-944. doi: 10.1126/science.134.3483.943
46. Holscher, C. (2012). Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection. CNS Drugs 26, 871-882. doi: 10.2165/11635890-000000000-00000
47. Holst, J. J. (2004). On the physiology of GIP and GLP-1. Horm. Metab. Res. 36, 747-754. doi: 10.1055/s-2004-826158
48. Hommel, J. D., Trinko, R., Sears, R. M., Georgescu, D., Liu, Z. W., Gao, X. B., et al. (2006). Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron 51, 801-810. doi: 10.1016/j.neuron.2006.08.023
49. Hsu, R., Taylor, J. R., Newton, S. S., Alvaro, J. D., Haile, C., Han, G., et al. (2005). Blockade of melanocortin transmission inhibits cocaine reward. Eur. J. Neurosci. 21, 2233-2242. doi: 10.1111/j.1460-9568.2005.04038.x
50. Imperato, A., and Di Chiara, G. (1986). Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J. Pharmacol. Exp. Ther. 239, 219-228.
51. Jin, S. L., Han, V. K., Simmons, J. G., Towle, A. C., Lauder, J. M., and Lund, P. K. (1988). Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study. J. Comp. Neurol. 271, 519-532. doi: 10.1002/cne.902710405
52. Kanoski, S. E., Rupprecht, L. E., Fortin, S. M., De Jonghe, B. C., and Hayes, M. R. (2012). The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide. Neuropharmacology 62, 1916-1927. doi: 10.1016/j.neuropharm.2011.12.022
53. Kim, S., Moon, M., and Park, S. (2009). Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease. J. Endocrinol. 202, 431-439. doi: 10.1677/JOE-09-0132
54. Kinzig, K. P., D'Alessio, D. A., and Seeley, R. J. (2002). The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness. J. Neurosci. 22, 10470-10476.
55. Koob, G. F. (1992). Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13, 177-184. doi: 10.1016/0165-6147(92)90060-J
56. Labouesse, M. A., Stadlbauer, U., Weber, E., Arnold, M., Langhans, W., and Pacheco-Lopez, G. (2012). Vagal afferents mediate early satiation and prevent flavour avoidance learning in response to intraperitoneally infused exendin-4. J. Neuroendocrinol. 24, 1505-1516. doi: 10.1111/j.1365-2826.2012.02364.x
57. Langhans, W. (2000). Anorexia of infection: current prospects. Nutrition 16, 996-1005. doi: 10.1016/S0899-9007(00)00421-4
58. Larsen, P. J., Tang-Christensen, M., Holst, J. J., and Orskov, C. (1997a). Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience 77, 257-270. doi: 10.1016/S0306-4522(96)00434-4
59. Larsen, P. J., Tang-Christensen, M., and Jessop, D. S. (1997b). Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat. Endocrinology 138, 4445-4455. doi: 10.1210/en.138.10.4445
60. Leggio, L. (2010). Role of the ghrelin system in alcoholism: acting on the growth hormone secretagogue receptor to treat alcohol-related diseases. Drug News Perspect. 23, 157-166. doi: 10.1358/dnp.2010.23.3.1429490
61. le Roux, C. W., and Bloom, S. R. (2005). Why do patients lose weight after Roux-en-Y gastric bypass. J. Clin. Endocrinol. Metab. 90, 591-592. doi: 10.1210/jc.2004-2211
62. Leshan, R. L., Opland, D. M., Louis, G. W., Leinninger, G. M., Patterson, C. M., Rhodes, C. J., et al. (2010). Ventral tegmental area leptin receptor neurons specifically project to and regulate cocaine- and amphetamine-regulated transcript neurons of the extended central amygdala. J. Neurosci. 30, 5713-5723. doi: 10.1523/JNEUROSCI.1001-10.2010
63. Li, Y., South, T., Han, M., Chen, J., Wang, R., and Huang, X. F. (2009). High-fat diet decreases tyrosine hydroxylase mRNA expression irrespective of obesity susceptibility in mice. Brain Res. 1268, 181-189. doi: 10.1016/j.brainres.2009.02.075
64. Lindblom, J., Opmane, B., Mutulis, F., Mutule, I., Petrovska, R., Klusa, V., et al. (2001). The MC4 receptor mediates alpha-MSH induced release of nucleus accumbens dopamine. Neuroreport 12, 2155-2158. doi: 10.1097/00001756-200107200-00022
65. Llewellyn-Smith, I. J., Reimann, F., Gribble, F. M., and Trapp, S. (2011). Preproglucagon neurons project widely to autonomic control areas in the mouse brain. Neuroscience 180, 111-121. doi: 10.1016/j.neuroscience.2011.02.023
66. Mack, C. M., Moore, C. X., Jodka, C. M., Bhavsar, S., Wilson, J. K., Hoyt, J. A., et al. (2006). Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures. Int. J. Obes. (Lond.) 30, 1332-1340. doi: 10.1038/sj.ijo.0803284
67. Mathes, C. M., Bueter, M., Smith, K. R., Lutz, T. A., le Roux, C. W., and Spector, A. C. (2012). Roux-en-Y gastric bypass in rats increases sucrose taste-related motivated behavior independent of pharmacological GLP-1-receptor modulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 302, R751-R767. doi: 10.1152/ajpregu.00214.2011
68. McMahon, L. R., and Wellman, P. J. (1998). PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats. Am. J. Physiol. 274, R23-R29.
69. Merchenthaler, I., Lane, M., and Shughrue, P. (1999). Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J. Comp. Neurol. 403, 261-280. doi: 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5
70. Miras, A. D., Jackson, R. N., Jackson, S. N., Goldstone, A. P., Olbers, T., Hackenberg, T., et al. (2012). Gastric bypass surgery for obesity decreases the reward value of a sweet-fat stimulus as assessed in a progressive ratio task. Am. J. Clin. Nutr. 96, 467-473. doi: 10.3945/ajcn.112.036921
71. Mul, J. D., Begg, D. P., Barrera, J. G., Li, B., Matter, E. K., D'Alessio, D. A., et al. (2013). High-fat diet changes the temporal profile of GLP-1 receptor-mediated hypophagia in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 305, R68-R77. doi: 10.1152/ajpregu.00588.2012
72. Naslund, E., Barkeling, B., King, N., Gutniak, M., Blundell, J. E., Holst, J. J., et al. (1999). Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int. J. Obes. Relat. Metab. Disord. 23, 304-311. doi: 10.1038/sj.ijo.0800818
73. Palmiter, R. D. (2007). Is dopamine a physiologically relevant mediator of feeding behavior. Trends Neurosci. 30, 375-381. doi: 10.1016/j.tins.2007.06.004
74. Palmiter, R. D. (2008). Dopamine signaling in the dorsal striatum is essential for motivated behaviors: lessons from dopamine-deficient mice. Ann. N.Y. Acad. Sci. 1129, 35-46. doi: 10.1196/annals.1417.003
75. Parkes, D. G., Mace, K. F., and Trautmann, M. E. (2013). Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1. Expert Opin. Drug Discov. 8, 219-244. doi: 10.1517/17460441.2013.741580
76. Patterson, J. T., Li, P., Day, J. W., Gelfanov, V. M., and DiMarchi, R. D. (2013). A hydrophobic site on the GLP-1 receptor extracellular domain orients the peptide ligand for signal transduction. Mol. Metab. 2, 86-91. doi: 10.1016/j.molmet.2013.01.003
77. Reimann, F. (2010). Molecular mechanisms underlying nutrient detection by incretin-secreting cells. Int. Dairy J. 20, 236-242. doi: 10.1016/j.idairyj.2009.11.014
78. Reimann, F., Habib, A. M., Tolhurst, G., Parker, H. E., Rogers, G. J., and Gribble, F. M. (2008). Glucose sensing in L cells: a primary cell study. Cell Metab. 8, 532-539. doi: 10.1016/j.cmet.2008.11.002
79. Ren, X., Ferreira, J. G., Zhou, L., Shammah-Lagnado, S. J., Yeckel, C. W., and de Araujo, I. E. (2010). Nutrient selection in the absence of taste receptor signaling. J. Neurosci. 30, 8012-8023. doi: 10.1523/JNEUROSCI.5749-09.2010
80. Rinaman, L. (1999a). A functional role for central glucagon-like peptide-1 receptors in lithium chloride-induced anorexia. Am. J. Physiol. 277, R1537-R1540.
81. Rinaman, L. (1999b). Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus. Am. J. Physiol. 277, R582-R590.
82. Rinaman, L. (2010). Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditure. Brain Res. 1350, 18-34. doi: 10.1016/j.brainres.2010.03.059
83. Robinson, S., Rainwater, A. J., Hnasko, T. S., and Palmiter, R. D. (2007). Viral restoration of dopamine signaling to the dorsal striatum restores instrumental conditioning to dopamine-deficient mice. Psychopharmacology (Berl.) 191, 567-578. doi: 10.1007/s00213-006-0579-9
84. Robinson, S., Sotak, B. N., During, M. J., and Palmiter, R. D. (2006). Local dopamine production in the dorsal striatum restores goal-directed behavior in dopamine-deficient mice. Behav. Neurosci. 120, 196-200. doi: 10.1037/0735-7044.120.1.000
85. Sandoval, D. A., Bagnol, D., Woods, S. C., D'Alessio, D. A., and Seeley, R. J. (2008). Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake. Diabetes 57, 2046-2054. doi: 10.2337/db07-1824
86. Schick, R. R., Zimmermann, J. P., vorm Walde, T., and Schusdziarra, V. (2003). Peptides that regulate food intake: glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284, R1427-R1435.
87. Seeley, R. J., Blake, K., Rushing, P. A., Benoit, S., Eng, J., Woods, S. C., et al. (2000). The role of CNS glucagon-like peptide-1 amide receptors in mediating the visceral illness effects of lithium chloride. J. Neurosci. 20, 1616-1621.
88. Sharma, S., Fernandes, M. F., and Fulton, S. (2013). Adaptations in brain reward circuitry underlie palatable food cravings and anxiety induced by high-fat diet withdrawal. Int. J. Obes. (Lond.). 37, 1183-1191.
89. Shin, A. C., and Berthoud, H. R. (2011). Food reward functions as affected by obesity and bariatric surgery. Int. J. Obes. (Lond.) 35(Suppl. 3), S40-S44. doi: 10.1038/ijo.2011.147
90. Shirazi, R. H., Dickson, S. L., and Skibicka, K. P. (2013). Gut peptide GLP-1 and its analogue, exendin-4, decrease alcohol intake and reward. PLoS ONE 8:e61965. doi: 10.1371/journal.pone.0061965
91. Shughrue, P. J., Lane, M. V., and Merchenthaler, I. (1996). Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus. Endocrinology 137, 5159-5162. doi: 10.1210/en.137.11.5159
92. Sjostrom, L., Narbro, K., Sjostrom, C. D., Karason, K., Larsson, B., Wedel, H., et al. (2007). Effects of bariatric surgery on mortality in Swedish obese subjects. N. Engl. J. Med. 357, 741-752. doi: 10.1056/NEJMoa066254
93. Skibicka, K. P., and Dickson, S. L. (2011). Ghrelin and food reward: the story of potential underlying substrates. Peptides 32, 2265-2273. doi: 10.1016/j.peptides.2011.05.016
94. Skibicka, K. P., Hansson, C., Alvarez-Crespo, M., Friberg, P. A., and Dickson, S. L. (2011). Ghrelin directly targets the ventral tegmental area to increase food motivation. Neuroscience 180, 129-137. doi: 10.1016/j.neuroscience.2011.02.016
95. Sotak, B. N., Hnasko, T. S., Robinson, S., Kremer, E. J., and Palmiter, R. D. (2005). Dysregulation of dopamine signaling in the dorsal striatum inhibits feeding. Brain Res. 1061, 88-96. doi: 10.1016/j.brainres.2005.08.053
96. Takeda, N., Hasegawa, S., Morita, M., and Matsunaga, T. (1993). Pica in rats is analogous to emesis: an animal model in emesis research. Pharmacol. Biochem. Behav. 45, 817-821. doi: 10.1016/0091-3057(93)90126-E
97. Talsania, T., Anini, Y., Siu, S., Drucker, D. J., and Brubaker, P. L. (2005). Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice. Endocrinology 146, 3748-3756. doi: 10.1210/en.2005-0473
98. Thiele, T. E., Seeley, R. J., D'Alessio, D., Eng, J., Bernstein, I. L., Woods, S. C., et al. (1998). Central infusion of glucagon-like peptide-1-(7-36) amide (GLP-1) receptor antagonist attenuates lithium chloride-induced c-Fos induction in rat brainstem. Brain Res. 801, 164-170. doi: 10.1016/S0006-8993(98)00584-8
99. Thiele, T. E., Van Dijk, G., Campfield, L. A., Smith, F. J., Burn, P., Woods, S. C., et al. (1997). Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats. Am. J. Physiol. 272, R726-R730.
100. Trapp, S., and Hisadome, K. (2011). Glucagon-like peptide 1 and the brain: central actions-central sources. Auton. Neurosci. 161, 14-19. doi: 10.1016/j.autneu.2010.09.008
101. Tuesta, L. M., Fowler, C. D., Lu, Q., and Kenny, P. J. (2012). "Role of glucagon-like peptide-1 (GLP-1) receptors in nicotine reinforcement," in Society for Neuroscience, Vol. Program No. 455.08/Q4 2012 Neuroscience Meeting Planner. New Orleans, LA: Society for Neuroscience.
102. Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M., Meeran, K., et al. (1996). A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379, 69-72. doi.org/10.1038/379069a0
103. Vucetic, Z., Kimmel, J., and Reyes, T. M. (2011). Chronic high-fat diet drives postnatal epigenetic regulation of μ-opioid receptor in the brain. Neuropsychopharmacology 36, 1199-1206. doi: 10.1038/npp.2011.4
104. Vucetic, Z., and Reyes, T. M. (2010). Central dopaminergic circuitry controlling food intake and reward: implications for the regulation of obesity. Wiley Interdiscip. Rev. Syst. Biol. Med. 2, 577-593. doi: 10.1002/wsbm.77
105. Wang, Y., Perfetti, R., Greig, N. H., Holloway, H. W., DeOre, K. A., Montrose-Rafizadeh, C., et al. (1997). Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats. J. Clin. Invest. 99, 2883-2889. doi: 10.1172/JCI119482
106. Williams, D. L., Hyvarinen, N., Lilly, N., Kay, K., Dossat, A., Parise, E., et al. (2011). Maintenance on a high-fat diet impairs the anorexic response to glucagon-like-peptide-1 receptor activation. Physiol. Behav. 103, 557-564. doi: 10.1016/j.physbeh.2011.04.005
107. Wilson-Pérez, H. E., Chambers, A. P., Ryan, K. K., Li, B., Sandoval, D. A., Stoffers, D., et al. (2013). Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like Peptide 1 receptor deficiency. Diabetes 62, 2380-2385. doi: 10.2337/db12-1498
108. Wise, R. A. (2004a). Dopamine and food reward: back to the elements. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R13. doi: 10.1152/ajpregu.00590.2003
109. Wise, R. A. (2004b). Dopamine, learning and motivation. Nat. Rev. Neurosci. 5, 483-494. doi: 10.1038/nrn1406
110. Wise, R. A. (2006). Role of brain dopamine in food reward and reinforcement. Philos. Trans. R. Soc. Lond. B Biol. Sci. 361, 1149-1158. doi: 10.1098/rstb.2006.1854
111. Wise, R. A., and Bozarth, M. A. (1984). Brain reward circuitry: four circuit elements "wired" in apparent series. Brain Res. Bull. 12, 203-208. doi: 10.1016/0361-9230(84)90190-4
112. Wise, R. A., and Bozarth, M. A. (1987). A psychomotor stimulant theory of addiction. Psychological. Rev. 94, 469-492. doi: 10.1037/0033-295X.94.4.469